Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013"
Open Access
- 4 November 2014
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 9 (1) , 224
Abstract
A brainstorming and consensus meeting organized by the German Cancer Aid focused on modern treatment of prostate cancer and promising innovative techniques and research areas. Besides optimization of screening algorithms, molecular-based stratification and individually tailored treatment regimens will be the future of multimodal prostate cancer management. Effective interdisciplinary structures, including biobanking and data collection mechanisms are the basis for such developments.Keywords
This publication has 35 references indexed in Scilit:
- A Multi-institutional Clinical Trial of Rectal Dose Reduction via Injected Polyethylene-Glycol Hydrogel During Intensity Modulated Radiation Therapy for Prostate Cancer: Analysis of Dosimetric OutcomesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Towards clinical evidence in particle therapy: ENLIGHT, PARTNER, ULICE and beyondJournal of Radiation Research, 2013
- American Society of Clinical Oncology Clinical Practice Guidelines: Formal Systematic Review–Based Consensus MethodologyJournal of Clinical Oncology, 2012
- Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical ProstatectomyEuropean Urology, 2012
- Prostate-Cancer Mortality at 11 Years of Follow-upNew England Journal of Medicine, 2012
- Transcription factor binding predictions using TRAP for the analysis of ChIP-seq data and regulatory SNPsNature Protocols, 2011
- Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09Journal of Clinical Oncology, 2010
- Androgen Receptor Coactivators Lysine-Specific Histone Demethylase 1 and Four and a Half LIM Domain Protein 2 Predict Risk of Prostate Cancer RecurrenceCancer Research, 2006
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: A case–control studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006